Division of Immunology, Boston Children's Hospital, Boston, Massachusetts 02115, USA.
Curr Opin Allergy Clin Immunol. 2012 Dec;12(6):623-8. doi: 10.1097/ACI.0b013e3283588ca6.
This review discusses the strengths and challenges of using whole genome sequencing (WGS)/whole exome sequencing (WES) for identifying novel genetic causes of primary immunodeficiencies.
WGS permits comprehensive sequencing of introns and exons, whereas WES allows deeper sequencing of exonic regions at a lower cost. Due to the large number of genetic variants found in each genome, it is necessary to use filtering approaches to distinguish deleterious from benign variants. WES has been used successfully to identify novel genetic causes of primary immunodeficiency. Complex structural variations and non-Mendelian disorders remain challenges for WGS/WES.
WGS/WES is a powerful screening tool with great potential to identify genetic causes of primary immunodeficiencies for research and clinical applications. To use WGS/WES effectively, it is necessary to understand how to filter the sequencing data and to realize its limitations as well as its strengths.
本综述讨论了全基因组测序(WGS)/全外显子组测序(WES)在鉴定原发性免疫缺陷症新的遗传原因方面的优势和挑战。
WGS 允许对内含子和外显子进行全面测序,而 WES 则可以在较低的成本下对外显子区域进行更深层次的测序。由于在每个基因组中都发现了大量的遗传变异,因此有必要使用过滤方法来区分有害和良性变异。WES 已成功用于鉴定原发性免疫缺陷症的新的遗传原因。复杂的结构性变异和非孟德尔疾病仍然是 WGS/WES 的挑战。
WGS/WES 是一种强大的筛选工具,具有很大的潜力,可以为研究和临床应用鉴定原发性免疫缺陷症的遗传原因。为了有效地使用 WGS/WES,有必要了解如何过滤测序数据,并认识到其局限性和优势。